Michael Fare
President at Skinject, Inc.
Profile
Michael J.
Fare is currently the President, Chief Operating Officer & Director at Skinject, Inc., a Director at Periovance, Inc., the COO & CTO at InClinica, Inc., and the Chief Operating Officer & Chief Technical Officer at Velocity Fund Partners since 2016.
He is also the Principal at Mediverse Consulting LLC since 2013.
Previously, he worked as a Director at Wyeth-Ayerst International LLC from 1984 to 1995 and as the Vice President-Operations at The Institutes for Pharmaceutical Discovery, Inc. Mr. Fare holds a graduate degree from Drexel University in 1984 and an undergraduate degree from St. Joseph's University in 1977.
Michael Fare active positions
| Companies | Position | Start |
|---|---|---|
| Mediverse Consulting LLC | Private Equity Investor | 2013-04-30 |
Velocity Fund Partners
 Velocity Fund Partners Investment ManagersFinance Velocity Fund Partners (Velocity Fund Partners) is a private equity firm founded in 2016. The firm is headquartered in Pittsburgh, Pennsylvania. | Chief Operating Officer | 2016-03-31 |
Skinject, Inc.
 Skinject, Inc. Hospital/Nursing ManagementHealth Services Skinject, Inc. operates as a biotechnology company. It offers treatment for common forms of non melanoma skin cancer, basal cell, and squamous cell carcinoma. The company was founded by Louis D. Falo and is headquartered in Pittsburgh, PA. | President | - |
Periovance, Inc.
 Periovance, Inc. Medical/Nursing ServicesHealth Services Periovance, Inc. is engaged in healthcare sector. The company is headquartered in Pittsburgh, PA. | Director/Board Member | - |
InClinica, Inc.
 InClinica, Inc. BiotechnologyHealth Technology InClinica, Inc. provides clinical trial services to western biotechnology, pharmaceutical and medical device companies. It also offers clinical trial management, pharmacovigilance and monitoring services. The company was founded in 2016 and is headquartered in Wayne, PA. | Chief Operating Officer | - |
Former positions of Michael Fare
| Companies | Position | End |
|---|---|---|
| Wyeth-Ayerst International LLC | Director/Board Member | 1994-12-31 |
The Institutes for Pharmaceutical Discovery, Inc.
 The Institutes for Pharmaceutical Discovery, Inc. BiotechnologyHealth Technology The Institutes for Pharmaceutical Discovery LLC was operated as a discovery research company. The company was founded in 1995 and was headquartered in Branford, CT. | Chief Operating Officer | - |
Training of Michael Fare
| Drexel University | Graduate Degree |
| St. Joseph's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
The Institutes for Pharmaceutical Discovery, Inc.
The Institutes for Pharmaceutical Discovery, Inc. BiotechnologyHealth Technology The Institutes for Pharmaceutical Discovery LLC was operated as a discovery research company. The company was founded in 1995 and was headquartered in Branford, CT. | Health Technology |
| Wyeth-Ayerst International LLC | |
| Mediverse Consulting LLC | |
Velocity Fund Partners
Velocity Fund Partners Investment ManagersFinance Velocity Fund Partners (Velocity Fund Partners) is a private equity firm founded in 2016. The firm is headquartered in Pittsburgh, Pennsylvania. | Finance |
Skinject, Inc.
Skinject, Inc. Hospital/Nursing ManagementHealth Services Skinject, Inc. operates as a biotechnology company. It offers treatment for common forms of non melanoma skin cancer, basal cell, and squamous cell carcinoma. The company was founded by Louis D. Falo and is headquartered in Pittsburgh, PA. | Health Services |
Periovance, Inc.
Periovance, Inc. Medical/Nursing ServicesHealth Services Periovance, Inc. is engaged in healthcare sector. The company is headquartered in Pittsburgh, PA. | Health Services |
InClinica, Inc.
InClinica, Inc. BiotechnologyHealth Technology InClinica, Inc. provides clinical trial services to western biotechnology, pharmaceutical and medical device companies. It also offers clinical trial management, pharmacovigilance and monitoring services. The company was founded in 2016 and is headquartered in Wayne, PA. | Health Technology |
- Stock Market
- Insiders
- Michael Fare